The board of directors of Johnson & Johnson (NYSE:JNJ) authorised a common stock cash dividend of USD1.01 per share for the first quarter of 2021, the company reported on Monday.
With an ex-dividend date of 22 February 2021, the dividend will be paid on 9 March 2021 to shareholders of record at the close of business on 23 February 2021.
Johnson & Johnson researches and develops, manufactures and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical and Medical Devices.
The company was founded in 1886 and is based in New Brunswick, New Jersey, USA.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development